AI空间生物标志物分析初创公司Nucleai成功筹集B+轮融资，总额达1400万美元
近日，AI空间生物标志物分析领域的初创公司Nucleai宣布成功筹集了新一轮的B+轮融资，总额为1400万美元。这次的投资由M Ventures领投，该公司的主要投资者Section 32、Sanofi Ventures、Debiopharm等也纷纷参与其中。同时，复星锐正资本、Vertex Ventures Israel以及Grove Ventures等投资公司也加入了本轮融资。
据悉，Nucleai公司专注于利用人工智能和机器学习技术，专注于在细胞和组织层面分析病理图像和空间数据，以预测治疗结果。这一创新技术有助于医药研究和临床治疗中做出更准确的决策，从而提高治疗效果并降低医疗成本。此次筹集的资金将用于进一步研发和创新，推动公司在AI医疗领域的发展。
此次融资的成功表明了市场对人工智能在医疗领域应用前景的看好，也反映出投资者对Nucleai公司技术实力和未来发展的信心。未来，Nucleai公司将继续致力于研发更先进的AI技术，助力全球医疗健康事业的发展。
英语如下：
News Title: “Nucleai Raises $14 Million in Series B+ Round, Using AI to Boost Spatial Biomarker Analysis and Innovate in Healthcare”
Key words: Nucleai funding, AI healthcare, spatial biomarker analysis
News Content:
AI Spatial Biomarker Analysis Startup Nucleai Raises $14 Million in Series B+ Round
Recently, Nucleai, a startup in the field of AI spatial biomarker analysis, announced the successful raising of a Series B+ round of funding, totaling $14 million. Led by M Ventures, this round also saw participation from Section 32, Sanofi Ventures, Debiopharm, and other major investors. In addition, investment companies such as Fosun瑞正资本, Vertex Ventures Israel, and Grove Ventures also joined this round of funding.
Nucleai focuses on utilizing artificial intelligence and machine learning technologies to analyze pathological images and spatial data at the cellular and tissue levels to predict treatment outcomes. This innovative technology helps to make more accurate decisions in medical research and clinical treatment, thereby improving treatment effects and reducing medical costs. The funds raised will be used for further research and development, as well as innovation, to drive the company’s development in the field of AI healthcare.
The success of this funding round demonstrates market confidence in the application prospects of artificial intelligence in the medical field, as well as investors’ confidence in Nucleai’s technological capabilities and future development. In the future, Nucleai will continue to focus on developing more advanced AI technologies to support the development of global healthcare.
【来源】https://www.calcalistech.com/ctechnews/article/r11brac1a
Views: 3